Osaic Holdings’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-16,829
| Closed | -$363K | – | 7815 |
|
|
2025
Q4 | $363K | Sell |
16,829
-31,685
| -65% | -$615K | ﹤0.01% | 3629 |
|
|
2025
Q3 | $717K | Sell |
48,514
-523
| -1% | -$6.8K | ﹤0.01% | 3098 |
|
|
2025
Q2 | $434K | Sell |
49,037
-509
| -1% | -$4.47K | ﹤0.01% | 3262 |
|
|
2025
Q1 | $388K | Sell |
49,546
-2,825
| -5% | -$23.7K | ﹤0.01% | 3092 |
|
|
2024
Q4 | $550K | Buy |
52,371
+34,819
| +198% | +$423K | ﹤0.01% | 2709 |
|
|
2024
Q3 | $230K | Buy |
17,552
+15,520
| +764% | +$236K | ﹤0.01% | 3536 |
|
|
2024
Q2 | $28.6K | Sell |
2,032
-3,226
| -61% | -$52.6K | ﹤0.01% | 5087 |
|
|
2024
Q1 | $88.8K | Sell |
5,258
-1,161
| -18% | -$17.3K | ﹤0.01% | 4329 |
|
|
2023
Q4 | $90.6K | Sell |
6,419
-14,178
| -69% | -$167K | ﹤0.01% | 4502 |
|
|
2023
Q3 | $212K | Buy |
20,597
+957
| +5% | +$12.8K | ﹤0.01% | 3950 |
|
|
2023
Q2 | $324K | Buy |
19,640
+2,439
| +14% | +$31.7K | ﹤0.01% | 3519 |
|
|
2023
Q1 | $158K | Sell |
17,201
-600
| -3% | -$4.93K | ﹤0.01% | 4060 |
|
|
2022
Q4 | $128K | Buy |
17,801
+1,700
| +11% | +$11.9K | ﹤0.01% | 4251 |
|
|
2022
Q3 | $81K | Buy |
16,101
+13,975
| +657% | +$76.9K | ﹤0.01% | 4541 |
|
|
2022
Q2 | $5K | Hold |
2,126
| – | – | ﹤0.01% | 6445 |
|
|
2022
Q1 | $15K | Sell |
2,126
-63
| -3% | -$433 | ﹤0.01% | 5868 |
|
|
2021
Q4 | $18K | Buy |
2,189
+23
| +1% | +$210 | ﹤0.01% | 5850 |
|
|
2021
Q3 | $21K | Sell |
2,166
-8,047
| -79% | -$63.4K | ﹤0.01% | 5723 |
|
|
2021
Q2 | $69K | Sell |
10,213
-1,000
| -9% | -$7.94K | ﹤0.01% | 4793 |
|
|
2021
Q1 | $101K | Hold |
11,213
| – | – | ﹤0.01% | 4331 |
|
|
2020
Q4 | $75K | Sell |
11,213
-4,738
| -30% | -$29.6K | ﹤0.01% | 4255 |
|
|
2020
Q3 | $80K | Buy |
15,951
+9,951
| +166% | +$72.4K | ﹤0.01% | 3986 |
|
|
2020
Q2 | $48K | Buy |
6,000
+5,300
| +757% | +$46.7K | ﹤0.01% | 4209 |
|
|
2020
Q1 | $6K | Buy |
+700
| New | +$5.38K | ﹤0.01% | 5245 |
|
Other funds holding AVDL
Osaic Holdings's AVDL Position: Q1 2026 in Review
Osaic Holdings sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 16,829 shares — an estimated $363K sold.
Osaic Holdings first reported a position in AVDL in Q1 2020 and held it in 24 quarters. The position peaked at $717K in Q3 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.
- Osaic Holdings reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Osaic Holdings sold 16,829 Avadel Pharmaceuticals shares in Q1 2026, an estimated $363K.
- Osaic Holdings first reported a position in Avadel Pharmaceuticals in Q1 2020 and held it in 24 quarters.
- Osaic Holdings's Avadel Pharmaceuticals position peaked at $717K in Q3 2025.
- 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.